Overview
- 45 inspections across 38 sites are on record.
- 69 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-07.
At a glance
Inspections
45
Sites
38
Observations
69
Career since
Oct 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Battelle Memorial Institute, BBRC | 7 May 2026 | Human Drugs | |
| Jiangsu Center for Safety Evaluation of Drugs | 3 Apr 2026 | Human Drugs | On file |
| Hubei Topgene Xinsheng Biotechnology Co., Ltd. | 27 Mar 2026 | Human Drugs | |
| Pharmaron (Beijing) TSP Services Limited | 1 Aug 2025 | Human Drugs | On file |
| WestChina-Frontier PharmaTech Co, Ltd | 25 Jul 2025 | Human Drugs | On file |
Sites inspected
Battelle Memorial Institute, BBRCWest Jefferson, United States1 insp.
Jiangsu Center for Safety Evaluation of DrugsNanjing, China1 insp.
Hubei Topgene Xinsheng Biotechnology Co., Ltd.Wuhan, China1 insp.
Pharmaron (Beijing) TSP Services LimitedBeijing, China1 insp.
WestChina-Frontier PharmaTech Co, LtdChengdu, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Mark J Seaton29 shared
Hugh M Mcclure9 shared
Carmen Y Fisher8 shared
Byungja E Marciante3 shared
Marshall A Naimo2 shared
Erin M Mcdowell2 shared
Kathryn Suttling2 shared
Andrew R Wasko2 shared
Deborah A Greco2 shared
David L Chon2 shared
Full investigator report
Get the verbatim findings behind Zhou Chen's 69 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site